It’s been anything but business as usual for Greg Wasson and Walgreen Co., and that seems to suit the president and CEO just fine.
The company, which rose to prominence through organic store-by-store growth, has been busy with acquisitions. It acquired North Carolina-based Kerr Drugs late last year for $173 million. The year before, it purchased a 45% stake in Europe’s Boots Alliance pharmacies, a $6.7 billion move that announced the company’s global intentions.
All access premium subscription
Why Subscribe To SN Digital Access?
Digital Access gives you unlimited online access to our most premium news and analysis such as October 2016. This includes in-depth stories and insights from our team of editors and guest writers as well as free eNewsletters, blogs, real-time polls, archives and more. In addition you will also receive complimentary access to the SN salary survey data tables.
Questions about your account or how to access content?
Contact: Desiree Torres [email protected]
Already a member? Please log in.